Bank of New York Mellon’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-123,329
| Closed | -$569K | – | 4334 |
|
2019
Q1 | $569K | Buy |
123,329
+4,895
| +4% | +$22.6K | ﹤0.01% | 3484 |
|
2018
Q4 | $414K | Buy |
118,434
+9,689
| +9% | +$33.9K | ﹤0.01% | 3577 |
|
2018
Q3 | $1.1M | Hold |
108,745
| – | – | ﹤0.01% | 3213 |
|
2018
Q2 | $787K | Buy |
108,745
+835
| +0.8% | +$6.04K | ﹤0.01% | 3381 |
|
2018
Q1 | $653K | Sell |
107,910
-483
| -0.4% | -$2.92K | ﹤0.01% | 3438 |
|
2017
Q4 | $1.04M | Sell |
108,393
-49,628
| -31% | -$478K | ﹤0.01% | 3215 |
|
2017
Q3 | $1.4M | Buy |
158,021
+1,550
| +1% | +$13.8K | ﹤0.01% | 3024 |
|
2017
Q2 | $1.98M | Buy |
156,471
+1,876
| +1% | +$23.7K | ﹤0.01% | 2858 |
|
2017
Q1 | $1.63M | Sell |
154,595
-321,450
| -68% | -$3.38M | ﹤0.01% | 2978 |
|
2016
Q4 | $4.38M | Sell |
476,045
-80,265
| -14% | -$739K | ﹤0.01% | 2387 |
|
2016
Q3 | $6.56M | Buy |
556,310
+50,151
| +10% | +$591K | ﹤0.01% | 2100 |
|
2016
Q2 | $6.55M | Buy |
506,159
+20,446
| +4% | +$265K | ﹤0.01% | 2072 |
|
2016
Q1 | $7.77M | Buy |
485,713
+338,392
| +230% | +$5.41M | ﹤0.01% | 1966 |
|
2015
Q4 | $4.22M | Buy |
147,321
+18,103
| +14% | +$518K | ﹤0.01% | 2319 |
|
2015
Q3 | $3.68M | Sell |
129,218
-17,835
| -12% | -$508K | ﹤0.01% | 2403 |
|
2015
Q2 | $5.28M | Buy |
147,053
+17,547
| +14% | +$630K | ﹤0.01% | 2321 |
|
2015
Q1 | $3.76M | Buy |
129,506
+2,888
| +2% | +$83.9K | ﹤0.01% | 2463 |
|
2014
Q4 | $2.67M | Buy |
126,618
+20,582
| +19% | +$434K | ﹤0.01% | 2664 |
|
2014
Q3 | $2.06M | Buy |
106,036
+16,108
| +18% | +$312K | ﹤0.01% | 2861 |
|
2014
Q2 | $1.41M | Buy |
89,928
+5,482
| +6% | +$85.6K | ﹤0.01% | 3120 |
|
2014
Q1 | $1.75M | Buy |
84,446
+224
| +0.3% | +$4.64K | ﹤0.01% | 2957 |
|
2013
Q4 | $1.09M | Sell |
84,222
-39,219
| -32% | -$506K | ﹤0.01% | 3250 |
|
2013
Q3 | $1.44M | Buy |
123,441
+80,721
| +189% | +$942K | ﹤0.01% | 3040 |
|
2013
Q2 | $197K | Buy |
+42,720
| New | +$197K | ﹤0.01% | 3761 |
|